Recent Innovations in Gelling Agents and Topical Gel Formulations for Psoriasis Treatment: A Patent Review

Abstract:

Psoriasis, a chronic inflammatory skin condition, is caused by an accelerated rate of skin cell turnover, leading to plaques, scaling, and inflammation. Commonly used conventional treatments for these symptoms include topical corticosteroids and vitamin D analogues. However, recent developments in gelling agents and topical gel formulations have significantly improved therapeutic outcomes, enhancing medicine administration and patient satisfaction. This patent study aims to analyze and gather the latest advancements in the production of topical gel formulations and gelling agents specifically designed to treat psoriasis. In addition to highlighting the innovative gel-based delivery systems' effectiveness and safety, this review also emphasizes how they improve patient adherence, convenience, and general quality of life. By looking at these developments, this review sheds light on how topical gel formulations and gelling agents are set to revolutionize psoriasis treatment in the future.